| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.011 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |